Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Radiodermatitis × Melatonin × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 5 Parasomnias 3 Tuberous Sclerosis 2 Smith-Magenis Syndrome 2 Neoplasms 2 Autism Spectrum Disorder 2 Angelman Syndrome 2 Weight Loss 1 Squamous Cell Carcinoma of Head and Neck 1 Sleep Wake Disorders 1 Sleep Disorders, Circadian Rhythm 1 Relapsed Malignant Solid Tumor 1 Radiodermatitis 1 Radiation Injuries 1 Polycystic Ovary Syndrome 1 Pain 1 Neoplasm Metastasis 1 Lung Neoplasms 1 Head and Neck Neoplasms 1 Gastrointestinal Neoplasms 1 Fatigue 1 Depression 1 Cachexia 1 Brain Neoplasms 1 Barrett Esophagus 1 Anorexia 1

Interventions

Low-Level Light Therapy 4 Curcumin 2 triethanolamine 1 eucerin 1 cetyl alcohol, propylene glycol, sodium lauryl sulfate non-lipid cleansing lotion 1 Zinc Oxide 1 Triamcinolone Acetonide 1 Standard of Care 1 Sodium Hypochlorite 1 Radiotherapy, Conformal 1 Melatonin 1 Gels 1 Dimethyl Sulfoxide 1 Biafine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03716583 2021-09-10

MELADERM

Herlev Hospital

Phase 2 Completed

Breast Neoplasms, Radiodermatitis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡